• Romidepsin (FK228): HDAC Inhibition, Spliceosome, and PARPi

  2026-08-04

  Explore the multifaceted roles of Romidepsin (FK228) as a potent HDAC inhibitor for cancer therapy research, with a unique focus on its impact on spliceosome regulation and synergistic potential with PARP inhibitors. Discover assay-relevant insights and protocol parameters that set this cornerstone apart.

• ANKLE2 Facilitates Zika Virus Replication via Membrane Remod

  2026-08-04

  Fishburn et al. provide mechanistic evidence that the host protein ANKLE2 is essential for efficient Zika virus (ZIKV) replication by regulating virus-induced membrane rearrangements. Their findings underscore a conserved role for ANKLE2 among orthoflaviviruses and highlight new research avenues in virus-host interactions and viral pathogenesis.

• ML133 HCl: Precision Potassium Channel Inhibitor for Kir2.1

  2026-08-03

  ML133 HCl enables researchers to dissect Kir2.1 potassium channel function with unprecedented selectivity, streamlining workflows in pulmonary artery smooth muscle cell proliferation and migration studies. Its robust inhibition profile and well-documented handling protocols position it as a gold-standard tool for cardiovascular ion channel research and disease modeling.

• Small-Molecule Inhibition of uPAR–uPA Blocks Cancer Invasion

  2026-08-03

  Khanna et al. pioneered the use of virtual screening against multiple urokinase receptor (uPAR) conformations to identify small-molecule inhibitors that disrupt the uPAR–uPA protein–protein interaction. Their findings establish a mechanistic basis for targeting this complex in cancer invasion and metastasis, informing translational research and protocol development.

• O-GlcNAcylation Modulates HUWE1–TfR1 Axis in Preeclampsia Fe

  2026-08-02

  This study provides mechanistic insight into how O-GlcNAc modification of HUWE1 regulates transferrin receptor 1 (TfR1) ubiquitination, impacting ferroptosis and syncytialization in preeclampsia. The findings reveal a new regulatory axis in placental iron homeostasis, suggesting possible molecular targets for improving pregnancy outcomes.

• S-nitrosylation of STOP1 and STAR1 Regulates Aluminum Resist

  2026-08-01

  This study elucidates how nitric oxide-mediated S-nitrosylation differentially regulates the stability of STOP1 and STAR1 proteins, coordinating external and internal aluminum resistance in Arabidopsis. These findings offer new insight into plant adaptation mechanisms to acidic soils and have practical implications for protein stability research in plant stress biology.

• SmD2 Acetylation, Spliceosome Modulation, and PARP Sensitivi

  2026-07-31

  This study reveals that acetylation-dependent regulation of the spliceosome core protein SmD2, mediated by p300 and HDAC2, alters alternative splicing and DNA repair in hepatocellular carcinoma (HCC). Targeting HDAC2 with Romidepsin destabilizes SmD2, sensitizing HCC cells to PARP inhibitors and suggesting a new therapeutic strategy for BRCA-wildtype tumors.

• Hyaluronic Acid-Enhanced ECM Scaffolds for Diabetic Wound Re

  2026-07-31

  This study presents a biomimetic, acellular dermal matrix-based sponge scaffold enriched with hyaluronic acid and polydopamine-deferoxamine nanoparticles. The innovation lies in its ability to promote vascularization and accelerate diabetic wound healing through photothermal warm bath therapy, offering a strategy for chronic wound management.

• Streptavidin – Cy5: Illuminating Biotin Detection in Cancer

  2026-07-30

  This article delivers strategic insight for translational scientists leveraging Streptavidin – Cy5 in advanced oncology workflows. It integrates mechanistic details of biotin detection with evidence from breast cancer signaling research, offering actionable guidance for optimizing immunofluorescence and flow cytometry. Drawing from primary literature and internal resources, it demonstrates how APExBIO’s Streptavidin – Cy5 elevates experimental rigor and translational impact—outlining both established protocols and the evolving landscape of molecular diagnostics.

• Leveraging JNJ-26481585 (Quisinostat) for Targeted Tumor Gro

  2026-07-30

  JNJ-26481585 (Quisinostat) stands out as a potent HDAC inhibitor that directly targets TRIM21-mediated tumor proliferation and drug resistance—unlocking a new dimension in epigenetic cancer research. This article distills the latest workflow enhancements, troubleshooting strategies, and comparative advantages for deploying Quisinostat in advanced oncology models.

• FPH1 (BRD-6125): Driving Next-Generation Hepatocyte Expansio

  2026-07-29

  Discover how FPH1 (BRD-6125) revolutionizes primary human hepatocyte culture, enabling robust, donor-independent expansion and precise functional enhancement. This article explores the molecular mechanism, assay design, and unique synergy with optogenetic gene regulation for advanced liver cell engineering.

• Vitamin D Receptor Drives Ferroptosis-Linked Salivary Hypose

  2026-07-29

  This study reveals that upregulation of the vitamin D receptor (VDR) enhances ferroptosis in the salivary glands of female Sod1 knockout mice, leading to impaired saliva secretion. The findings establish a mechanistic link between oxidative stress, sex-specific ferroptosis, and glandular dysfunction, informing future research on targeted therapies for xerostomia.

• Redefining Apoptosis: TNF-alpha Tools for Translational Impa

  2026-07-28

  This thought-leadership article explores how recombinant murine TNF-alpha, especially as supplied by APExBIO, is empowering translational researchers to dissect apoptosis and inflammation mechanisms in the wake of paradigm-shifting findings about regulated cell death. Integrating cutting-edge mechanistic insight, workflow guidance, and competitive benchmarking, we reveal how TNF-alpha recombinant murine protein is now central to next-generation disease modeling, immune modulation, and therapy discovery.

• Caspase-3 Colorimetric Assay Kit: Technical Application Guid

  2026-07-28

  The Caspase-3 Colorimetric Assay Kit enables precise, DEVD-dependent detection of caspase-3 activity in apoptosis and neurodegeneration research. It is optimized for rapid and reproducible quantification in diverse biological samples, but should not be used for mechanistic pathway dissection beyond caspase-3 without additional validation.

• D-Luciferin Potassium Salt: Illuminating ATP Dynamics in Tra

  2026-07-27

  Explore how D-Luciferin (potassium salt) empowers translational researchers to visualize cellular energy dynamics, track disease progression, and optimize experimental workflows. This article synthesizes mechanistic insight from recent plant-pathogen studies with strategic guidance for in vivo imaging and reporter assays. Discover how APExBIO’s gold-standard substrate bridges foundational biochemistry with emerging applications in oncology, infectious disease, and beyond.

451 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page